VACOP-B vs VACOP-B plus high-dose sequential therapy (RDS) for aggressive non-Hodgkin's lymphoma (NHL).

被引：0
|
作者：
Santini, G [1 ]
Olivieri, A [1 ]
Majolino, I [1 ]
Chisesi, T [1 ]
Salvagno, L [1 ]
Biglio, A [1 ]
de Souza, C [1 ]
Congiu, M [1 ]
Rizzoli, V [1 ]
机构：
[1] Osped San Martino Genova, Dept Haematol, Genoa, Italy
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3576
引用
收藏
页码：862A / 862A
页数：1
相关论文
共 50 条
  • [21] VACOP/B, high-dose cytoxan and high-dose therapy with PBPC rescue for aggressive nhl with bone marrow involvement: Clinical and prognostic significance
    Santini, G
    Congiu, AM
    Olivieri, A
    Coser, P
    Guarnaccia, C
    Maiolino, I
    Chisesi, T
    Leoni, P
    Salvagno, L
    Porcellini, A
    Sertoli, MR
    Rubagotti, A
    Rizzoli, V
    BONE MARROW TRANSPLANTATION, 1999, 23 : S163 - S163
  • [22] High-dose therapy for aggressive non-Hodgkin's lymphoma
    Pettengell, R
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1996, 56 (10): : 521 - 524
  • [23] Rituximab Combined With MACOP-B or VACOP-B and Radiation Therapy in Primary Mediastinal Large B-Cell Lymphoma: A Retrospective Study
    Zinzani, Pier Luigi
    Stefoni, Vittorio
    Finolezzi, Erica
    Brusamolino, Ercole
    Cabras, Maria Giuseppina
    Chiappella, Annalisa
    Salvi, Flavia
    Rossi, Andrea
    Broccoli, Alessandro
    Martelli, Maurizio
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (05): : 381 - 385
  • [24] VACOP/B, high-dose cytoxan and high-dose therapy with PBPC rescue for aggressive NHL with bone marrow involvement: Clinical and prognostic significance.
    Santini, G
    Congiu, M
    Olivieri, A
    Coser, P
    Guamaccia, C
    Malolino, I
    Chisesi, T
    Leoni, P
    Salvagno, L
    Porcellini, A
    Sertoli, MR
    Rubagotti, A
    Rizzoli, V
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (07) : 125 - 125
  • [25] VACOP-B WITH AZT AND HEMATOPOIETIC GROWTH-FACTOR (HGF) SUPPORT WITH GM-CSF AND EPO IN HIV-RELATED NON-HODGKINS-LYMPHOMA (NHL)
    SOFER, D
    MASON, B
    STADDON, A
    FORD, P
    GRIMES, M
    RENSMAN, B
    DANNA, R
    FRANDE, J
    GELFAND, L
    HENRY, D
    BLOOD, 1994, 84 (10) : A649 - A649
  • [26] Short high-dose CHOP chemotherapy for aggressive non-Hodgkin's lymphoma (NHL).
    Epelbaum, R
    Dann, E
    Drumea, K
    Haim, N
    Ben-Shahar, M
    Faraggi, D
    Rowe, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 584S - 584S
  • [27] Aggressive non-Hodgkin's lymphoma - Economics of high-dose therapy
    Beard, SM
    Wall, L
    Gaffney, L
    Sampson, F
    PHARMACOECONOMICS, 2004, 22 (04) : 207 - 224
  • [28] CHEMOTHERAPY WITH MACOP-B AND VACOP-B FOR INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - CLINICAL-RESULTS AND ANALYSIS OF PROGNOSTIC FACTORS
    PICHERT, G
    PETERS, J
    STAHEL, RA
    DOMMANN, C
    JOSS, R
    GEBBERS, JO
    KRONER, T
    SULSER, H
    HONEGGER, HP
    MAURER, R
    PAMPALLONA, S
    ANNALS OF ONCOLOGY, 1992, 3 (08) : 645 - 649
  • [29] Aggressive Non-Hodgkin’s LymphomaEconomics of High-Dose Therapy
    Stephen M. Beard
    Lucy Wall
    Louise Gaffney
    Fiona Sampson
    PharmacoEconomics, 2004, 22 : 207 - 224
  • [30] High-dose therapy and transplantation in non-Hodgkin's lymphoma
    Morrison, VA
    Peterson, BA
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 84 - 98
12345